Noorwegen - Noors - Statens legemiddelverk

bluefish pharmaceuticals ab - venlafaksinhydroklorid - depotkapsel, hard - 75 mg

Noorwegen - Noors - Statens legemiddelverk

bluefish pharmaceuticals ab - venlafaksinhydroklorid - depotkapsel, hard - 150 mg

Noorwegen - Noors - Statens legemiddelverk

merz pharmaceuticals gmbh, frankfurt, tyskland - botulinumtoksin type a - pulver til injeksjonsvæske, oppløsning - 100 e

Noorwegen - Noors - Statens legemiddelverk

merz pharmaceuticals gmbh, frankfurt, tyskland - botulinumtoksin type a - pulver til injeksjonsvæske, oppløsning - 50 e

Noorwegen - Noors - Statens legemiddelverk

merz pharmaceuticals gmbh - botulinumtoksin type a - pulver til injeksjonsvæske, oppløsning - 200 e

Europese Unie - Noors - EMA (European Medicines Agency)

sfl pharmaceuticals deutschland gmbh - nyxthracis - anthrax - immune sera og immunglobuliner, - obiltoxaximab sfl is indicated in combination with appropriate antibacterial drugs in all age groups for treatment of inhalational anthrax due to bacillus anthracis (see section 5. obiltoxaximab sfl is indicated in all age groups for post-exposure prophylaxis of inhalational anthrax when alternative therapies are not appropriate or are not available (see section 5.

Europese Unie - Noors - EMA (European Medicines Agency)

esteve pharmaceuticals gmbh - tiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastiske midler - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Noorwegen - Noors - Statens legemiddelverk

merz pharmaceuticals gmbh - botulinumtoksin type a - pulver til injeksjonsvæske, oppløsning - 50 e

Noorwegen - Noors - Statens legemiddelverk

merz pharmaceuticals gmbh - botulinumtoksin type a - pulver til injeksjonsvæske, oppløsning - 100 e

Europese Unie - Noors - EMA (European Medicines Agency)

mylan pharmaceuticals limited - teriflunomide - multippel sklerose, relapsing-remitting - immunsuppressive - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).